AI Buyer Insights:

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

PharmaEssentia Data, Technology Stack, and Enterprise Applications
IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
Amazon Web Services (AWS) Legacy Amazon EC2 Application Hosting and Computing Services IaaS n/a 2024 2024
Content Delivery Network IaaS 2024 2024
PLM and Engineering
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
IDBS Legacy IDBS Polar Life Science R&D Platforms PLM and Engineering n/a 2024 2024 In 2024, PharmaEssentia implemented IDBS Polar as a Life Science R&D Platforms solution to enable collaboration between its new Innovation Research Center in Boston and its Taipei R&D organization. The Boston PIRC deployment will onboard an initial 15 users expanding to 25 users, with a subsequent onboarding of about 65 Taipei users who will be securely connected to the Boston instance to create a unified data environment. The implementation emphasizes electronic laboratory notebook capability that extends beyond traditional ELN functionality, delivering structured data capture, experiment record keeping, and a single chain of custody for experimental data. IDBS Polar was selected for its multi-language capability including Mandarin, and for platform capabilities that include dynamic inventory management directly tied to experimental workflows, with scope to expand into AI ML analytics and reporting. Operational coverage centers on laboratory R&D workflows across discovery and early development functions, aligning experimental protocols, materials and sample tracking between sites. The deployment configures inventory management inside experimental workflows so that equipment, materials and samples can be tracked dynamically as part of the scientific process, preserving provenance and enabling cross-site data interrogation. PharmaEssentia executed a phased rollout with training and demonstrations to address cultural and process change in the Taipei team that had been using paper records, which helped accelerate adoption. Governance practices reflect a single source of truth approach, standardized experiment documentation and collaborative workflows to support learning from both successful and failed experiments, and future expansion into analytics and reporting as platform usage grows.
CyberSecurity
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
Amazon Web Services (AWS) Legacy Amazon WAF Web Application Firewalls (WAF) CyberSecurity n/a 2024 2024
IT Decision Makers and Key Stakeholders at PharmaEssentia
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by PharmaEssentia Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD PharmaEssentia Technographics

PharmaEssentia is a Life Sciences organization based in Taiwan, with around 500 employees and annual revenues of $158.0 million.

PharmaEssentia operates a diverse technology stack with applications such as Amazon EC2, IDBS Polar and Amazon WAF, covering areas like Application Hosting and Computing Services, Life Science R&D Platforms and Web Application Firewalls (WAF).

PharmaEssentia has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Amazon Web Services (AWS) and IDBS.

PharmaEssentia recently adopted applications including Amazon EC2 in 2024, Amazon CloudFront in 2024 and IDBS Polar in 2024, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of PharmaEssentia’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates PharmaEssentia’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete PharmaEssentia technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.